Asma M. Aman

3.8k total citations
45 papers, 1.5k citations indexed

About

Asma M. Aman is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Asma M. Aman has authored 45 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 12 papers in Genetics and 9 papers in Oncology. Recurrent topics in Asma M. Aman's work include Glioma Diagnosis and Treatment (12 papers), Epigenetics and DNA Methylation (6 papers) and Protein Degradation and Inhibitors (6 papers). Asma M. Aman is often cited by papers focused on Glioma Diagnosis and Treatment (12 papers), Epigenetics and DNA Methylation (6 papers) and Protein Degradation and Inhibitors (6 papers). Asma M. Aman collaborates with scholars based in Canada, United States and United Kingdom. Asma M. Aman's co-authors include Rima Al‐awar, Samuel Weiss, Xianqi Kong, H. Artee Luchman, Julie Paquette, Aaron D. Schimmer, Mounia Azzi, Céline Morissette, Patrick Tremblay and Diane Lacombe and has published in prestigious journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and SHILAP Revista de lepidopterología.

In The Last Decade

Asma M. Aman

42 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Asma M. Aman Canada 20 693 238 234 196 156 45 1.5k
Ivana Campia Italy 22 567 0.8× 269 1.1× 129 0.6× 91 0.5× 127 0.8× 28 1.2k
John L. Stebbins United States 26 1.2k 1.7× 411 1.7× 133 0.6× 255 1.3× 110 0.7× 39 2.0k
Stefania Sartini Italy 25 651 0.9× 230 1.0× 80 0.3× 548 2.8× 66 0.4× 56 1.7k
Yangbo Feng United States 31 1.7k 2.5× 368 1.5× 234 1.0× 523 2.7× 190 1.2× 65 2.6k
Xiaohong Shu China 26 934 1.3× 315 1.3× 142 0.6× 189 1.0× 43 0.3× 63 1.8k
Anna Laurenzana Italy 29 1.2k 1.8× 461 1.9× 186 0.8× 186 0.9× 163 1.0× 77 2.3k
Antonio Pezone Italy 15 1.2k 1.8× 280 1.2× 127 0.5× 204 1.0× 136 0.9× 30 2.3k
Manon Carré France 27 1.1k 1.6× 675 2.8× 82 0.4× 349 1.8× 132 0.8× 65 2.3k
Giovanni Galasso Italy 16 1.1k 1.6× 445 1.9× 89 0.4× 209 1.1× 138 0.9× 24 2.4k
Loretta Lazzarato Italy 27 691 1.0× 560 2.4× 277 1.2× 689 3.5× 164 1.1× 89 2.4k

Countries citing papers authored by Asma M. Aman

Since Specialization
Citations

This map shows the geographic impact of Asma M. Aman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Asma M. Aman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Asma M. Aman more than expected).

Fields of papers citing papers by Asma M. Aman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Asma M. Aman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Asma M. Aman. The network helps show where Asma M. Aman may publish in the future.

Co-authorship network of co-authors of Asma M. Aman

This figure shows the co-authorship network connecting the top 25 collaborators of Asma M. Aman. A scholar is included among the top collaborators of Asma M. Aman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Asma M. Aman. Asma M. Aman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Woolman, Michael, David G. Muñoz, Taira Kiyota, et al.. (2025). A molecular array for 10-second diagnosis of common spinal tumor types with picosecond infrared laser mass spectrometry. Neuro-Oncology. 27(8). 2060–2072.
2.
Aman, Asma M., et al.. (2025). Enhanced biomedical performance of magnetic Fe3O4@chitosan nanocomposites: A comparative study of synthesis methods for hyperthermia and chemotherapy applications. SHILAP Revista de lepidopterología. 19. 100142–100142. 2 indexed citations
3.
Wong, Jong Fu, Carlos Zepeda‐Velázquez, Laurent Hoffer, et al.. (2024). Discovery of Conformationally Constrained ALK2 Inhibitors. Journal of Medicinal Chemistry. 67(6). 4707–4725. 3 indexed citations
4.
Woolman, Michael, Taira Kiyota, Vijay Ramaswamy, et al.. (2024). Lipidomic-Based Approach to 10 s Classification of Major Pediatric Brain Cancer Types with Picosecond Infrared Laser Mass Spectrometry. Analytical Chemistry. 96(3). 1019–1028. 7 indexed citations
5.
Tata, Alessandra, Taira Kiyota, Michael Woolman, et al.. (2024). A Workflow for Meaningful Interpretation of Classification Results from Handheld Ambient Mass Spectrometry Analysis Probes. International Journal of Molecular Sciences. 25(6). 3491–3491. 3 indexed citations
6.
Adile, Ashley, David Bakhshinyan, Yujin Suk, et al.. (2023). An effective kinase inhibition strategy for metastatic recurrent childhood medulloblastoma. Journal of Neuro-Oncology. 163(3). 635–645. 2 indexed citations
7.
Kiyota, Taira, Michael Woolman, Megan Wu, et al.. (2023). Metabolic Lipids in Melanoma Enable Rapid Determination of Actionable BRAF-V600E Mutation with Picosecond Infrared Laser Mass Spectrometry in 10 s. Analytical Chemistry. 95(38). 14430–14439. 2 indexed citations
8.
Woolman, Michael, Taira Kiyota, Layla Pires, et al.. (2022). Picosecond Infrared Laser Mass Spectrometry Identifies a Metabolite Array for 10 s Diagnosis of Select Skin Cancer Types: A Proof-of-Concept Feasibility Study. Analytical Chemistry. 94(48). 16821–16830. 10 indexed citations
9.
Barghout, Samir H., Mandeep Mann, Asma M. Aman, et al.. (2022). Combinatorial Anticancer Drug Screen Identifies Off-Target Effects of Epigenetic Chemical Probes. ACS Chemical Biology. 17(10). 2801–2816. 7 indexed citations
10.
Mann, Mandeep, Carlos Zepeda‐Velázquez, Aiping Dong, et al.. (2021). Structure–Activity Relationship of USP5 Inhibitors. Journal of Medicinal Chemistry. 64(20). 15017–15036. 13 indexed citations
11.
Uehling, David, Babu Joseph, Kim Chan Chung, et al.. (2021). Design, Synthesis, and Characterization of 4-Aminoquinazolines as Potent Inhibitors of the G Protein-Coupled Receptor Kinase 6 (GRK6) for the Treatment of Multiple Myeloma. Journal of Medicinal Chemistry. 64(15). 11129–11147. 16 indexed citations
12.
Barghout, Samir H., Asma M. Aman, Kazem Nouri, et al.. (2021). A genome-wide CRISPR/Cas9 screen in acute myeloid leukemia cells identifies regulators of TAK-243 sensitivity. JCI Insight. 6(5). 24 indexed citations
13.
Smil, David, Carlos Zepeda‐Velázquez, Dimitrios Panagopoulos, et al.. (2020). Targeting ALK2: An Open Science Approach to Developing Therapeutics for the Treatment of Diffuse Intrinsic Pontine Glioma. Journal of Medicinal Chemistry. 63(9). 4978–4996. 15 indexed citations
14.
Woolman, Michael, Claudia M. Kuzan-Fischer, Taira Kiyota, et al.. (2019). Picosecond Infrared Laser Desorption Mass Spectrometry Identifies Medulloblastoma Subgroups on Intrasurgical Timescales. Cancer Research. 79(9). 2426–2434. 38 indexed citations
15.
Tu, William B., Yu-Jia Shiah, Corey Lourenco, et al.. (2018). MYC Interacts with the G9a Histone Methyltransferase to Drive Transcriptional Repression and Tumorigenesis. Cancer Cell. 34(4). 579–595.e8. 86 indexed citations
16.
17.
Lun, Xueqing, J. Connor Wells, Natalie Grinshtein, et al.. (2016). Disulfiram when Combined with Copper Enhances the Therapeutic Effects of Temozolomide for the Treatment of Glioblastoma. Clinical Cancer Research. 22(15). 3860–3875. 169 indexed citations
18.
Hammoud, Lamis, Jessica R. Adams, Amanda J. Loch, et al.. (2016). Identification of RSK and TTK as Modulators of Blood Vessel Morphogenesis Using an Embryonic Stem Cell-Based Vascular Differentiation Assay. Stem Cell Reports. 7(4). 787–801. 14 indexed citations
19.
Deng, Tao, Jeff C. Liu, Philip E.D. Chung, et al.. (2014). shRNA Kinome Screen Identifies TBK1 as a Therapeutic Target for HER2+ Breast Cancer. Cancer Research. 74(7). 2119–2130. 29 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ivana Campia Breakdown of academic impact, for papers by John L. Stebbins Breakdown of academic impact, for papers by Stefania Sartini Breakdown of academic impact, for papers by Yangbo Feng Breakdown of academic impact, for papers by Xiaohong Shu Breakdown of academic impact, for papers by Anna Laurenzana Breakdown of academic impact, for papers by Antonio Pezone Breakdown of academic impact, for papers by Manon Carré Breakdown of academic impact, for papers by Giovanni Galasso Breakdown of academic impact, for papers by Loretta Lazzarato
Rankless by CCL
2026